Skip to main content
Premium Trial:

Request an Annual Quote

Thomas McNally, Howard Kelly, Bob Thian, Hinrich Kehler, Tony Hunter, Tony Pawson, Alexander Levitzki, and Patricia Goldsmith

Premium

Thomas McNally has become vice chairman of Whatman, assuming functions from Howard Kelly, who stepped down as CEO in November, the company said last week. McNally, already a non-executive director of Whatman, will retain his new position until a new CEO is appointed. Previously, he held various positions at Abbott Laboratories.

Also, Bob Thian, chairman of Whatman, will be responsible for the integration and management of Schleicher & Schuell, which Whatman acquired in November.

In addition, Hinrich Kehler, until recently chairman of Schleicher & Schuell, has been appointed as a non-executive director. He holds a PhD in physical chemistry.


Tony Hunter, Tony Pawson, and Alexander Levitzki have been jointly awarded the 2005 Wolf Prize in Medicine for their research in cancer development and treatment, the Wolf Foundation said last week. They will equally share the $100,000 prize, which will be presented to them in Jerusalem on May 22.

Hunter, a professor of biology at the Salk Institute, is recognized for discovering tyrosine protein kinases. He holds a PhD from the University of Cambridge, UK.

Pawson, a senior scientist at the Samuel Lunenfeld Research Institute at Mount Sinai Hospital in Toronto and a professor at the University of Toronto, is cited for discovering protein domains essential for mediating protein-protein interactions in cell signaling. He holds a PhD in molecular biology from London University and a BA in biochemistry from Cambridge University.

Levitzki is recognized for developing tyrosine kinase inhibitors to treat cancer, paving the way for drugs such as Gleevec. He is is a professor of biochemistry at the Hebrew University of Jerusalem. Levitzki holds a PhD in biochemistry and biophysics from Hebrew University and the Weizmann Institute of Science.


Patricia Goldsmith has become senior vice president of business development, public affairs, and policy at the National Comprehensive Cancer Network, NCCN said this week. She used to be vice president for institutional development, public affairs, and marketing at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Fla., an NCCN member institution.

 

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.